Skip to main content

Table 1 Patients’ characteristics

From: Microvascular alterations in patients with SARS-COV-2 severe pneumonia

Male (n,  %)

10 (83.3%)

Age (years)

56 (10)

BMI (kg/m2)

31.6 (5.4)

Comorbidities (n, %)

 Dyslipidemia

4 (33.3%)

 Hypertension

3 (25.0%)

 Diabetes type 2

2 (16.7%)

 Ischemic cardiomyopathy

2 (16.7%)

Tidal volume (ml)

421 (190)

RR (breath/min)

13 (3)

Pplat (cmH2O)

27 (5)

PEEP (cmH2O)

10 (8.6; 13.8)

∆P (cmH2O)

13 (4)

Cstat (ml/cmH2O)

52 (37)

FiO2

0.40 (0.35; 0.48)

PaO2/FiO2 (mmHg)

207 (88)

VV-ECMO (n,  %)

6 (50.0%)

CRRT (n,  %)

2 (16.7%)

MAP (mmHg)

88 (13)

HR (beat/min)

86 (23)

Lactate (mmo/l)

1.16 (0.41)

WBC (×109/l)

14.12 (5.13)

IL-6 (pg/ml)

138 (18.5; 338)

D-Dimer (ng/ml)

788 (717; 5536)

Noradrenaline

 n (%)

9 (75%)

 mcg/kg/min

0.24 (0.14)

Propofol

 n (%)

9 (75%)

 mg/kg/h

2.5 (0.46)

Midazolam

 n (%)

9 (75%)

 mg/kg/h

0.26 (0.12)

Remifentanil

 n (%)

12 (100%)

 mcg/kg/min

0.1 (0.85; 0.1)

  1. Data reported as n. (%); mean (standard deviation); median (interquartile range)
  2. BMI body mass index, CRRT continuous renal replacement therapy, Cstat static compliance of respiratory system, FiO2 inspiratory fraction of oxygen, HR heart rate, IL-6 interleukin 6, MAP mean arterial pressure, PaO2 arterial partial pressure of oxygen, ∆P driving pressure, PEEP positive end expiratory pressure, Pplat plateau pressure, RR respiratory rate, VV-ECMO veno-venous extracorporeal membrane oxygenation, WBC white blood cells